✦ LIBER ✦

Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience

✍ Scribed by Michael B. Sprakes; P. John Hamlin; Lisa Warren; Dan Greer; Alexander C. Ford

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gastrointestinal: Improvement of granulo

✍ Scott B. Fanning; Grace Chapman; Yunki Yau; Rupert WL Leong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Anti tumour necrosis factor as risk fact

✍ E. J. Eshuis; G. H. M. J. Griffioen; P. C. F. Stokkers; D. T. Ubbink; W. A. Beme 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Steroid-free remission and closure of re

✍ Sara Onali; Francesca Zorzi; Emma Calabrese; Livia Biancone 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 450 KB